Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 17, 2021
Inhibition of NF-κB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosisJade Jaffar, Ian Glaspole, Karen Symons, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 3, 2009
Administration of cyclophosphamide changes the immune profile of tumor-bearing micePu Liu, Jade Jaffar, Ingegerd Hellstrom, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Inhibition of TGFbeta1 makes nonimmunogenic tumor cells effective for therapeutic vaccinationPu Liu, Jade Jaffar, Yifeng Zhou, et al.Scientific Reports|February 1, 2017
The fibrogenic actions of lung fibroblast-derived urokinase: a potential drug target in IPFMichael Schuliga, Jade Jaffar, Trudi Harris, et al.BMC Medical Education|March 2, 2022
Establishing CREATE: lessons learned in setting up a training environment for early-career researchers in respiratory medicineKatherine Christian, Alison Hey-Cunningham, Tamera Corte, et al.Cancer Letters|April 13, 2010
Detection of the HE4 protein in urine as a biomarker for ovarian neoplasmsIngegerd Hellstrom, Patrick J Heagerty, Elizabeth M Swisher, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|March 9, 2018
Greater cellular stiffness in fibroblasts from patients with idiopathic pulmonary fibrosisJade Jaffar, Soung-Hee Yang, Sally Yunsun Kim, et al.Respiratory Research|August 27, 2020
CXCR4<sup>+</sup> cells are increased in lung tissue of patients with idiopathic pulmonary fibrosisJade Jaffar, Kate Griffiths, Sara Oveissi, et al.Clinical & Translational Immunology|January 25, 2024
Multi-omics integration reveals a nonlinear signature that precedes progression of lung fibrosisCéline Pattaroni, Christina Begka, Bailey Cardwell, et al.Cancer Research|March 3, 2007
Tumor cells expressing anti-CD137 scFv induce a tumor-destructive environmentYi Yang, Shilin Yang, Zhengmao Ye, et al.Pageof 4